Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
Salem
Mohamed
M
Elrefai
Sara
S
Shrit
M Atef
MA
Warkentin
Theodore E
TE
D000368:Aged; D000906:Antibodies / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000209:etiology*; D008297:Male; D010978:Platelet Factor 4 / Q000276:immunology; D011134:Polysaccharides / Q000009:adverse effects* / Q000276:immunology; D020521:Stroke / Q000209:etiology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000906:Antibodies; D000925:Anticoagulants; D011134:Polysaccharides; D010978:Platelet Factor 4; D006493:Heparin; D000077425:Fondaparinux